145 related articles for article (PubMed ID: 26064686)
1. Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis?
Jongen PJ; Wesnes K; van Geel B; Pop P; Schrijver H; Visser LH; Gilhuis HJ; Sinnige LG; Brands AM
Mult Scler Int; 2015; 2015():960282. PubMed ID: 26064686
[TBL] [Abstract][Full Text] [Related]
2. Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remitting multiple sclerosis.
Jongen PJ; Wesnes K; van Geel B; Pop P; Sanders E; Schrijver H; Visser LH; Gilhuis HJ; Sinnige LG; Brands AM;
PLoS One; 2014; 9(5):e96444. PubMed ID: 24787714
[TBL] [Abstract][Full Text] [Related]
3. Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study.
Jongen PJ; Ruimschotel R; Heerings M; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; Wolper H; van Droffelaar M; Lemmens W; Donders R; Visser LH
Health Qual Life Outcomes; 2014 Mar; 12():40. PubMed ID: 24646061
[TBL] [Abstract][Full Text] [Related]
4. Effect of an intensive 3-day social cognitive treatment (can do treatment) on control self-efficacy in patients with relapsing remitting multiple sclerosis and low disability: A single-centre randomized controlled trial.
Jongen PJ; van Mastrigt GA; Heerings M; Visser LH; Ruimschotel RP; Hussaarts A; Duyverman L; Valkenburg-Vissers J; Cornelissen J; Bos M; van Droffelaar M; Donders R
PLoS One; 2019; 14(10):e0223482. PubMed ID: 31600271
[TBL] [Abstract][Full Text] [Related]
5. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
6. An intensive social cognitive program (can do treatment) in people with relapsing remitting multiple sclerosis and low disability: a randomized controlled trial protocol.
Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Evers S; Duyverman L; Valkenburg-Vissers J; Cornelissen J; Bos M; van Droffelaar M; Lemmens WA; Donders R; van der Zande A; Visser LH
BMC Neurol; 2016 May; 16():81. PubMed ID: 27234001
[TBL] [Abstract][Full Text] [Related]
7. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
Håkansson I; Johansson L; Dahle C; Vrethem M; Ernerudh J
Mult Scler Relat Disord; 2019 Nov; 36():101424. PubMed ID: 31586802
[TBL] [Abstract][Full Text] [Related]
8. Caregiver strain among life partners of persons with mild disability due to relapsing-remitting multiple sclerosis.
van der Hiele K; van Gorp DAM; Heerings MAP; Jongen PJ; van der Klink JJL; Beenakker EAC; van Eijk JJJ; Frequin STFM; van Geel BM; Hengstman GJD; Hoitsma E; Mostert JP; Verhagen WIM; de Gans K; Zemel D; Middelkoop HAM; Visser LH
Mult Scler Relat Disord; 2019 Jun; 31():5-11. PubMed ID: 30877926
[TBL] [Abstract][Full Text] [Related]
9. Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; van Droffelaar M; Lemmens W; Donders R; Visser LH
BMC Res Notes; 2016 Jul; 9():375. PubMed ID: 27473375
[TBL] [Abstract][Full Text] [Related]
10. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
[TBL] [Abstract][Full Text] [Related]
11. Erratum.
Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
[TBL] [Abstract][Full Text] [Related]
12. Functional Magnetic Resonance Imaging Correlations Between Fatigue and Cognitive Performance in Patients With Relapsing Remitting Multiple Sclerosis.
Iancheva D; Trenova A; Mantarova S; Terziyski K
Front Psychiatry; 2019; 10():754. PubMed ID: 31749716
[TBL] [Abstract][Full Text] [Related]
13. Cognitive symptoms and correlates of physical disability in individuals with multiple sclerosis.
Fraser C; Stark S
J Neurosci Nurs; 2003 Dec; 35(6):314-20. PubMed ID: 14713097
[TBL] [Abstract][Full Text] [Related]
14. Social cognitive correlates of physical activity among persons with multiple sclerosis: Influence of depressive symptoms.
Ensari I; Kinnett-Hopkins D; Motl RW
Disabil Health J; 2017 Oct; 10(4):580-586. PubMed ID: 28363457
[TBL] [Abstract][Full Text] [Related]
15. Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
Pavsic K; Pelicon K; Ledinek AH; Sega S
Clin Neurol Neurosurg; 2015 Dec; 139():35-40. PubMed ID: 26363365
[TBL] [Abstract][Full Text] [Related]
16. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome.
Sandi D; Biernacki T; Szekeres D; Füvesi J; Kincses ZT; Rózsa C; Mátyás K; Kása K; Matolcsi J; Zboznovits D; Burány Z; Langane É; Vécsei L; Bencsik K
Mult Scler Relat Disord; 2017 Oct; 17():57-62. PubMed ID: 29055476
[TBL] [Abstract][Full Text] [Related]
19. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
[TBL] [Abstract][Full Text] [Related]
20. An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability.
van Mastrigt GA; Evers SM; Heerings M; Visser LH; Ruimschotel RP; Hussaarts A; Duyverman L; Valkenburg-Vissers J; Cornelissen J; Bos M; van Droffelaar M; Jongen PJ
J Med Econ; 2019 Oct; 22(10):967-980. PubMed ID: 31084442
[No Abstract] [Full Text] [Related]
[Next] [New Search]
